Fig. 3From: Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trialFrequency of cells before the start of SBRT between good and bad responders. a Frequency of Memory Th17 cells, Naive Th17 cells and CD8+ lymphocytes before the start of SBRT in 1 bad responding study patient compared to 1 good responding study patient. b Boxplot comparing the frequency of Memory Th17 cells, Naive Th17 cells and CD8+ lymphocytes before start of SBRT between bad responding and good responding patientsBack to article page